ESR1 and breast cancer: In the present study, miR-342 expression was shown to be positively correlated with the expression of ERα in human breast cancer tissues and the introduction of miR-342 into estrogen-dependent breast cancer cells was shown to upregulate ERα expression and enhance tamoxifen sensitivity with decreased cellular proliferation and increased apoptosis.